No two cancers are alike. Neither should the treatment.
Personalized oncology uses your tumor's unique genetic fingerprint to identify the therapies most likely to work โ and avoid those unlikely to help. OncoCyprus is your bridge to the world-leading laboratories that perform this advanced testing.
Molecular profiling โ performed by world-leading labs
The DNA and RNA of your tumor are sequenced by internationally accredited reference laboratories to detect mutations, fusions, expression patterns, and immune signatures. OncoCyprus does not run the sequencing itself โ we coordinate access to the labs that do.
Targeted therapy matching โ reported by the lab
The partner laboratory maps each biomarker to FDA-approved targeted therapies, immunotherapies, and active clinical trials in Europe and the US, prioritized by level of evidence. The report is issued by the lab and shared with your oncologist.
Access to world-class laboratories
Our role is to connect patients in Cyprus with the same internationally accredited reference laboratories trusted by leading cancer centers worldwide โ handling sample logistics from collection to delivery. The clinical testing itself is performed by these partner labs.
Continuous monitoring through partner labs
Liquid biopsy testing run by our partner laboratories tracks how your cancer evolves under treatment โ detecting resistance early so your oncologist can adapt therapy in real time.